Market Pulse Archives

Nov. 3, 2021, 6:14 a.m. EDT

Teva Pharmaceuticals plans $5 billion sustainability-linked bond tied to climate and access to medicine targets

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Teva Pharmaceutical Industries Ltd. ADR (TEVA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Ciara Linnane

Teva Pharmaceutical Industries Ltd. /zigman2/quotes/205657894/composite TEVA -3.05% said Wednesday it is planning to execute a $5 billion sustainability-linked bond that will be tied to climate and access to medicine targets. The Israeli generics company said the bond is the biggest of its kind from any sector and first issued by a generics company. The bond will be tied to a 25% reduction in Scope 1 and 2 greenhouse gas emissions and a 150% increase in access to essential medicines for patients in low- and middle-income countries by the end of 2025. Teva said it is also the only drug company to issue a bond with both social and environmental targets. The company recently said it is targeting reducing Scope 3 GHG emissions by 25% by 2030. It will disclose its performance against each target in its annual ESG Progress report. Shares were down 0.8% premarket and have gained about 5% in the year to date, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -1.84% has gained 23%.

/zigman2/quotes/205657894/composite
US : U.S.: NYSE
$ 8.89
-0.28 -3.05%
Volume: 8.96M
Jan. 18, 2022 4:00p
P/E Ratio
13.55
Dividend Yield
N/A
Market Cap
$10.20 billion
Rev. per Employee
$407,986
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,577.11
-85.74 -1.84%
Volume: 2.74B
Jan. 18, 2022 4:56p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.